We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The UK’s healthcare costs regulator is recommending Medtronic’s integrated automated glucose monitoring system for managing blood glucose levels in some people with Type 1 diabetes. Read More
Next month, an FDA advisory committee will consider Angel Medical Systems’ PMA application for its implantable cardiac monitor that notifies patients about changes that could signal an oncoming heart attack. Read More